Intranasal influenza vaccine can now be self-administered by adults or administered by a caregiver, as an alternative to administration by a healthcare professional.
Findings from a large randomized clinical trial of household contacts helped get oral ensitrelvir approved for COVID-19 post-exposure prophylaxis in the U.S. and Japan.
The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked.
Based on recent guidance from the National Advisory Committee on Immunization, all of the following are strongly recommended to receive TWO doses of COVID-19 vaccine per year, EXCEPT for . . .